Jun 14, 2023 / 05:00PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome to our continued morning here at the third day of the Goldman Sachs Healthcare Conference. My name is Chris Shibutani, member of the research team on the global front, along with many strong associates across the board, who are being very supportive and very helpful. We are super pleased to be able to have Sanofi join us here. A very important discovery, perhaps you can say your last name because I think even focusing your C-suite are doing variations on it. So here's your chance man.
William J. Sibold - Sanofi - Executive VP of Specialty Care & President of Sanofi North America
See, that's disappointing to hear folks in the C-suite saying that, but no, it's Bill Sibold.
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Bill, tell us a little bit about your professional journey. I always like to make this a conversation between us in this moment of time, probably a lot of grumpy people out
Sanofi SA at Goldman Sachs Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers